Qingdao Meipeptide Technology
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Qingdao Meipeptide Technology between 22 Feb 2026 and 28 Apr 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Qingdao Meipeptide Technology
Retatrutide
Tested 4 Samples
Last test 28 Apr 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Qingdao Meipeptide Technology
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
28 Apr 2026
First
22 Feb 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 28 Apr 2026 | View | 20mg | 21.1mg | +5.5% | 99.30% | below LOQ | rt20 258014 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 28 Apr 2026 | View | 5mg | 4.63mg | -7.4% | 99.90% | n/a | rt5 0314-1 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 26 Apr 2026 | View | 10mg | 10.2mg | +2.0% | 98.60% | below LOQ | rt10 258013 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 22 Feb 2026 | View | 20mg | 21mg | +5.0% | 99.90% | n/a | 258014 | No Label / Silver Crimp / White Cap | Lab E | Public | |